References
- Smith B R, Hall R. Thyroid-stimulating immunoglobulins in Graves' disease. Lancet 1974; ii: 427–431
- Davies T F, Evered D C, Smith B R, Yeo P PB, Clark F, Hall R. Value of thyroid-stimulating immunoglobulins in predicting short-term thyrotoxic relapse. Lancet 1977; i: 1181–1182
- Sridama V, Pacini F, DeGroot L J. Decreased suppressor T lymphocytes in autoimmune thyroid diseases detected by monoclonal antibodies. J Clin Endocrinol Metab 1982; 54: 316–319
- Thielemans C, Vanhaelst L, de Waele M, Jonckher M, van Camp B. Autoimmune thyroiditis: A condition related to a decrease in T-suppressor cells. Clin Endocrinol 1981; 15: 259–263
- Ludgate M E, McGregor A M, Weetman A P, Ratnachaiyavong S, Lazarus J M, Hall R, Middleton G W. Analysis of T cell subsets in Graves' disease: alterations associated with carbimazole. Brit Med J 1984; 288: 526–530
- Kennedy R, Di Mario U, Pozzilli P, Guy K, Leonardi M, Sensi M, Andreani D. Activated T cells in Graves' disease before treatment. Clin Exp Immunol 1985; 59: 377–382
- Southgate K, Creagh F, Teece M, Kingswood C, Smith B R. A receptor assay for the measurement of TSH receptor antibodies in unextracted serum. Clin Endocrinol 1984; 10: 539–543
- Di Mario U, Guy K. Evaluation of class II antigen positive T cells: A simple double staining method using monoclonal antibodies. J Clin Lab Immunol 1984; 13: 203–204
- Eisenbarth G S, Haynes B F, Schroer J A, Fauci A S. Production of monoclonal antibodies reacting with peripheral blood mononuclear cell differentiation antigens. J Immunol 1980; 124: 1237–1244
- Haynes B F, Hemler M R, Mann D L, Eisenbarth G S, Shelhamer J, Mostowski H S, Thomas C A, Strominger J L, Fauci A S. Characterization of a monoclonal antibody (4F2) that binds to human monocytes and to a subset of activated lymphocytes. J Immunol 1981; 126: 1409–1414
- Carlsson M, Matsson P, Rosen A, Sundstrom C, Totterman T H, Nilsson K. Phorbol ester and B cell-stimulatory factor synergize to induce B-chronic lymphocytic leukaemia cells to simultaneous immunoglobulin secretion and DNA synthesis. Leukemia 1988; 2: 734–744
- Kerhl J H, Muraguchi A, Fauci A S. Differential expression of cell activation markers after stimulation of resting human B lymphocytes. J Immunol 1984; 132: 2857–2861
- Cotner T, Williams J M, Christensen L, Shapiro H M, Strom T B, Strominger J. Simultaneous flow cytometric analysis of human T cell activation antigen expression and DNA content. J Exp Med 1983; 157: 461–472
- Kennedy R, Di Mario U, Pozilli P, Guy K, Leonardi M, Sensi M, Andreani D. Activated T cells in Graves' disease before treatment. Clin Exp Immunol 1985; 59: 377–382
- Kennedy R L, Kadlubowski M, Di Mario U, Irvine W J. Recurrent Graves' disease: Humoral and cell-mediated immunity. J Endocrinol 1986; 108: 171, Suppl
- Canonica G W, Bagnasco M, Corte G, Ferrini S, Ferrini O, Giordano G. Circulating T lymphocytes in Hashimoto's disease: Imbalance of subsets and presence of activated cells. Clin Immunol Imm-unopathol 1982; 23: 616–625